Cargando…
Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
Autores principales: | Garg, Mayur, Christensen, Britt, Lubel, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184986/ https://www.ncbi.nlm.nih.gov/pubmed/32353370 http://dx.doi.org/10.1053/j.gastro.2020.04.051 |
Ejemplares similares
-
Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?
por: Hanrahan, Timothy P., et al.
Publicado: (2021) -
COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism
por: Pirola, Carlos J., et al.
Publicado: (2020) -
IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020) -
COVID-19: Colorectal cancer endoscopic surveillance in IBD
por: Din, Shahida, et al.
Publicado: (2021) -
What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
por: Taxonera, Carlos, et al.
Publicado: (2021)